Peculiarities of Pain in Patients With Gunshot Wounds Depending on the Localization of the Wound at the Stages of Treatment (PPPGWDL)

August 4, 2022 updated by: Vasyl' Horoshko, Bogomolets National Medical University
Chronic pain, in turn, is associated with a whole cohort of mutually aggravating factors - this can lead to the development of extremely serious long-term consequences. The features of pain in this category of patients have not been sufficiently studied. Taking into account continuity and consistency, clear and high-quality pain treatment is necessary at all stages of treatment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The peculiarities of pain in patients with gunshot wounds, depending on the localization of the wound at the stages of treatment, need to be studied, because the subjective feelings and emotional experiences experienced by patients during the wounding in combat conditions through the prism of psychological disorders have their own characteristics.

Study Type

Observational

Enrollment (Actual)

1555

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Ukraine
      • Kyiv, Ukraine
        • Bogomolets National Medical University, Ministry of Health of Ukraine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Male

Sampling Method

Probability Sample

Study Population

all patients were injured during hostilities

Description

Inclusion Criteria:

  • the presence of gunshot wounds

Exclusion Criteria:

  • no gunshot wounds

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
retrospective analysis
A retrospective analysis of disease histories for the period from 2014 to 2021 was carried out. Data collection was carried out at all stages of treatment: medical and nursing brigade, military mobile hospital, military medical clinical center, during rehabilitation, within 12 months of the injury.
Other: visual analog scale
Data collection was carried out at all stages of treatment: medical and nursing brigade, military mobile hospital, military medical clinical center, during rehabilitation, within 12 months of the injury.
Other Names:
  • neuropathic pain Didier Bouhassiraa DN4
  • Chaban Quality of Life Scale
  • The Hospital Anxiety and Depression Scale (HADS)
  • Mississippi scale of post-traumatic stress disorders (military version) (MS PTSD (m))
prospective study
Recruitment of patients for the prospective study was carried out in the period from 02.24.2022 to 05.24.2022
Other: visual analog scale
Data collection was carried out at all stages of treatment: medical and nursing brigade, military mobile hospital, military medical clinical center, during rehabilitation, within 12 months of the injury.
Other Names:
  • neuropathic pain Didier Bouhassiraa DN4
  • Chaban Quality of Life Scale
  • The Hospital Anxiety and Depression Scale (HADS)
  • Mississippi scale of post-traumatic stress disorders (military version) (MS PTSD (m))

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
visual analog scale
Time Frame: 12 months
from 0 to 10 points
12 months
pain diagnostic questionnaire
Time Frame: 12 months
4 or more points (a neuropathic pain component is present)
12 months
The Hospital Anxiety and Depression Scale
Time Frame: 12 months
0-7 is the norm 8-13 - mild depressive disorders 14-18 - depressive disorders of medium severity 19-22 - severe depressive disorders 23 and more - depressive disorders of a very severe degree of severity
12 months
Chaban Quality of Life Scale
Time Frame: 12 months
up to 56 inclusive - a very low level 57-66 - low 67-75 - average 76-82 - tall 83-100 is very high
12 months
Mississippi PTSD scale (military version)
Time Frame: 12 months
the mean values of the total score are 76±18 for well-adjusted servicemen, 86±26 for servicemen with mental disorders, and 130±18 for those with PTSD
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bogomolets National Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 24, 2022

Primary Completion (Actual)

May 24, 2022

Study Completion (Actual)

May 24, 2022

Study Registration Dates

First Submitted

August 1, 2022

First Submitted That Met QC Criteria

August 3, 2022

First Posted (Actual)

August 5, 2022

Study Record Updates

Last Update Posted (Actual)

August 8, 2022

Last Update Submitted That Met QC Criteria

August 4, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • №158/23.05.2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

I plan to share

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on visual analog scale

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe